Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression of Interleukin-2 via down regulation of its target gene, 05/May/2014, 5.44 am

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression of Interleukin-2 via down regulation of its target gene, 05/May/2014, 5.44 am

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression of Interleukin-2 via down regulation of its target gene, 05/May/2014, 5.44 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression  of Interleukin-2  via down regulation of its target gene, 05/May/2014, 5.44 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing